Zhang Renpan, Li Lixiang, Chen Bin, Liu Hong, Liu Jing, Zhang Liangzhi, Xiu Zhongbiao
The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350004.
Fujian University of Traditional Chinese Medicine, Fuzhou 350122, Fujian Province, China.
Medicine (Baltimore). 2019 Sep;98(36):e17051. doi: 10.1097/MD.0000000000017051.
Knee osteoarthritis (KOA), a common clinical chronic osteoarthropathy, has adverse effects on the working ability and life quality of patients. At present, acupotomy and nonsteroidal anti-inflammatory drugs (NSAIDs) have been widely applied on KOA in China and has achieved satisfactory results. However, there is no systematic review comparing the effectiveness of these two therapies for KOA. Therefore, this study will assess the efficacy and safety of acupotomy in treating KOA.
Several databases including CNKI, Wanfang Database, CBM, VIP, PubMed, Cochrane library, Web of Science, and Embase will be used by two independent researchers to search the related clinical RCTs about acupotomy therapy for KOA patients until May 2019. Subsequently, meta-analysis will be conducted by using Review Manager 5.3, and the related data will be analyzed by using the method for GRADE. The continuous data will be presented as the WMD or SMD with 95% CI, while dichotomous data will be shown as the RR with 95% CI.
Our results review will provide evidence to determine whether acupotomy can achieve the effect of NSAIDs, or whether it has advantages and safety compared with NSAIDs for patients with KOA.
This study will not involve personal information. The ethical approval will not be required. This systematic review will be disseminated electronically through a peer-reviewed journal or international conference presentations.
CRD42019129089.
膝关节骨关节炎(KOA)是一种常见的临床慢性骨关节炎,对患者的工作能力和生活质量有不良影响。目前,针刀和非甾体类抗炎药(NSAIDs)在中国已广泛应用于KOA,并取得了满意的效果。然而,尚无系统评价比较这两种疗法对KOA的有效性。因此,本研究将评估针刀治疗KOA的疗效和安全性。
两名独立研究人员将使用包括中国知网、万方数据库、中国生物医学文献数据库、维普资讯、PubMed、Cochrane图书馆、科学引文索引和Embase在内的多个数据库,检索截至2019年5月有关针刀治疗KOA患者的相关临床随机对照试验(RCTs)。随后,将使用Review Manager 5.3进行荟萃分析,并使用GRADE方法分析相关数据。连续数据将以加权均数差(WMD)或标准化均数差(SMD)及95%可信区间(CI)表示,二分数据将以风险比(RR)及95%CI表示。
我们的结果综述将为确定针刀是否能达到NSAIDs的效果,或与NSAIDs相比对KOA患者是否具有优势和安全性提供证据。
本研究不涉及个人信息,无需伦理批准。本系统评价将通过同行评审期刊或国际会议报告以电子方式传播。
PROSPERO注册号:CRD42019129089。